OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synergistic anti-tumor effect of dual drug co-assembled nanoparticles based on ursolic acid and sorafenib
Ling-Wu Tong, Jingqing Le, Xun-Huan Song, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 234, pp. 113724-113724
Closed Access | Times Cited: 6
Ling-Wu Tong, Jingqing Le, Xun-Huan Song, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 234, pp. 113724-113724
Closed Access | Times Cited: 6
Showing 6 citing articles:
Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis
Ruirui Zhao, Juhong Wu, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 257-276
Closed Access | Times Cited: 4
Ruirui Zhao, Juhong Wu, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 257-276
Closed Access | Times Cited: 4
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 4
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 4
The Antitumor and Sorafenib-resistant Reversal Effects of Ursolic Acid on Hepatocellular Carcinoma via Targeting ING5
Yinjie Fan, Fu-Zhi Pan, Zheng‐Guo Cui, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 11, pp. 4190-4208
Open Access
Yinjie Fan, Fu-Zhi Pan, Zheng‐Guo Cui, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 11, pp. 4190-4208
Open Access
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
Chenicheri K. Keerthana, Sreekumar U. Aiswarya, Tennyson P. Rayginia, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1431-1441
Closed Access
Chenicheri K. Keerthana, Sreekumar U. Aiswarya, Tennyson P. Rayginia, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1431-1441
Closed Access
Docetaxel-tethered di-Carboxylic Acid Derivatised Fullerenes: A Promising Drug Delivery Approach for Breast Cancer
Charu Misra, Jasleen Kaur, Mahesh Kumar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access
Charu Misra, Jasleen Kaur, Mahesh Kumar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access
Active herbal ingredients and drug delivery design for tumor therapy: a review
Jing Han, Y. Shen, Ruiying Cao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 12, pp. 1134-1162
Closed Access
Jing Han, Y. Shen, Ruiying Cao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 12, pp. 1134-1162
Closed Access
